AstraZeneca-Merck Lynparza gets EMA's positive recommendation

Drugmakers AstraZeneca Plc and Merck & Co Inc said on Monday their blockbluster cancer drug, Lynparza, has received positive recommendation from the European Medicines Agency (EMA) as a maintenance treatment for a form of pancreatic cancer.


from Reuters: Health News https://ift.tt/2XmwWYg

Comentarii

Postări populare de pe acest blog

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

6 Easy Mother’s Day Gifts for the Mom Who Says She Doesn’t Want Anything